Tag: Shreehas Tambe
Biocon clocks Rs 4,519 crore revenue in Q3 of FY24, earns...
The company revenue in biosimilars went up by 65%; research services up by 9%; EBITDA stood at Rs 1,492 Crore, up 106%; Net Profit at Rs 660 Crore
Biocon Biologics recognized as an Asia IP Elite for 2023, IPR...
Biocon Biologics is one among the three pharmaceutical companies from India to be featured on this year’s list.
Biocon Biologics announces divestment of two non-core branded formulations business units
The move is in line with the company’s strategy to sharpen focus on core therapy areas as a fully integrated biosimilars company
Shreehas Tambe appointed as MD & CEO of Biocon Biologics
Mr Tambe takes over from Dr Arun Chandavarkar, who will continue to serve as a non-Executive, non-Independent Director on the Board of Biocon Biologics